Loading...

Codexis, Inc.

0I0X.LLSE
Healthcare
Biotechnology
£2.87
£0.22(8.30%)

Codexis, Inc. (0I0X.L) Financial Performance & Income Statement Overview

Review Codexis, Inc. (0I0X.L) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.

Revenue Growth
-15.39%
15.39%
Operating Income Growth
14.03%
14.03%
Net Income Growth
14.38%
14.38%
Operating Cash Flow Growth
6.13%
6.13%
Operating Margin
-134.40%
134.40%
Gross Margin
69.08%
69.08%
Net Profit Margin
-149.47%
149.47%
ROE
-118.47%
118.47%
ROIC
722.62%
722.62%

Codexis, Inc. (0I0X.L) Income Statement & Financial Overview

Review Codexis, Inc. 0I0X.L income statement with detailed quarterly and annual figures.

MetricQ4 2024Q3 2024Q2 2024Q1 2024
Revenue$21.46M$12.83M$7.98M$17.07M
Cost of Revenue$3.65M$4.32M$4.70M$6.11M
Gross Profit$17.81M$8.52M$3.28M$10.97M
Gross Profit Ratio$0.83$0.66$0.41$0.64
R&D Expenses$12.10M$11.51M$10.39M$10.21M
SG&A Expenses$13.05M$13.57M$15.45M$12.64M
Operating Expenses$25.15M$25.07M$25.84M$22.85M
Total Costs & Expenses$28.80M$29.39M$30.55M$28.96M
Interest Income$940000.00$849000.00$972000.00$909000.00
Interest Expense-$6.42M$4.92M$985000.00$0.00
Depreciation & Amortization-$1.16M$1.99M$2.03M$2.02M
EBITDA-$9.91M-$13.68M-$20.72M-$9.86M
EBITDA Ratio-$0.46-$1.07-$2.60-$0.58
Operating Income-$7.34M-$16.56M-$22.57M-$11.89M
Operating Income Ratio-$0.34-$1.29-$2.83-$0.70
Other Income/Expenses (Net)-$3.03M-$4.07M-$13000.00$393000.00
Income Before Tax-$10.37M-$20.63M-$22.75M-$11.49M
Income Before Tax Ratio-$0.48-$1.61-$2.85-$0.67
Income Tax Expense$3000.00$10000.00$10000.00$10000.00
Net Income-$10.38M-$20.64M-$22.75M-$11.51M
Net Income Ratio-$0.48-$1.61-$2.85-$0.67
EPS-$0.13-$0.29-$0.32-$0.16
Diluted EPS-$0.13-$0.29-$0.32-$0.16
Weighted Avg Shares Outstanding$81.30M$72.03M$70.38M$69.85M
Weighted Avg Shares Outstanding (Diluted)$81.30M$72.03M$70.38M$69.85M

Over the last four quarters, Codexis, Inc.'s revenue moved from $17.07M in Q1 2024 to $21.46M in Q4 2024. Operating income in Q4 2024 was -$7.34M, with a strong operating margin of -34%. Despite fluctuations in R&D and SG&A expenses, EBITDA for Codexis, Inc. remained robust at -$9.91M, reflecting operational efficiency. Net income rose to -$10.38M, with an EPS of -$0.13. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;